LOSING PATENT FIGHTS IN INDIA.

The article deals with the pharmaceutical patent system implemented in India. The country's Patent Office grants patents for major innovations in drugs, but not for derivatives, new applications, combinations, or new formulas. According to Eric Noehrenberg, head of Noehrenberg International Policy Consultancy, the country is following the recommendations of nongovernmental organizations (NGOs) and is establishing a strict definition of innovation. Novartis aims to change the patent law of India.